IDIQ - TO - Human Pharm - Tobacco Use Study 8
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $3,000,000 to $7,000,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541618 Other Management Consulting Services
- Points of contact
-
- Ajmal Hussain ajmal.hussain@fda.hhs.gov
- tbd@fda.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Department of Health and Human Services Food and Drug Administration (FDA) is forecasting an Indefinite Delivery/Indefinite Quantity (IDIQ) task order for a Human Pharmaceutical Tobacco Use Study (Study 8). This procurement falls under the Management Consulting Services category (NAICS 541618) and is planned for solicitation release on May 1, 2026, with an estimated award date of July 1, 2026. The study appears to be focused on research related to tobacco use, likely involving comprehensive data collection and analysis.
The primary point of contact for this opportunity is Ajmal Hussain, who can be reached at ajmal.hussain@fda.hhs.gov within the FDA organization. While specific award values and detailed performance requirements are not currently available in the forecast, the contract is positioned as a new requirement with no specific set-aside designation. Potential vendors should be prepared to demonstrate expertise in pharmaceutical research, tobacco use studies, and management consulting services to be competitive for this federal contract opportunity.
Forecast text
IDIQ - TO - Human Pharm - Tobacco Use Study 8
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast